December 18, 2024- Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software company, announced that they have entered into a strategic partnership, in the U.S. to enhance cardiovascular care through the utilization of both ePRISM – Terumo’s proprietary clinical decision support platform – and Medis’ Quantitative Flow Ratio (QFR) technology, a non-invasive software solution designed to assess angiography-derived coronary physiology. The use of ePRISM and Medis QFR will be piloted at selected clinical sites, leveraging real-time data from electronic health records to provide prospective insights to help enhance patient care.
THO’s partnership with Netherlands-based Medis Medical Imaging represents a significant step in enhancing clinical decision support capabilities, streamlining workflows and, most importantly, improving patient outcomes by providing interventional cardiologists with precise anatomical and physiological assessments of coronary artery disease (CAD).